The program does include a transition plan to help people ease back into normal eating, but the responsibility for maintaining weight ultimately lies with the individual
Ozempic is a GLP-1 receptor agonist licensed in the UK specifically for type 2 diabetes treatment, working through enhanced insulin secretion, reduced glucagon release, delayed gastric emptying, and appetite suppression
Graham Thoms, chief executive of Pharmadoctor, which provides clinical services and support to independent pharmacies, said: In addition to putting additional pressure on the Mounjaro supply chain, which can lead to shortages, it is simply not clinically appropriate to provide patients with multiple pens of Mounjaro at one time, and could put patients health at risk. Pharmadoctor partner pharmacies should make sure each patient has a face-to-face consultation every four weeks before they can be provided with another four weeks supply of Mounjaro to ensure it is clinically appropriate to continue their treatment, he added
Effects of acute and chronic administration of GIP analogues on cognition, synaptic plasticity and neurogenesis in mice
Bioavailability of dietary glutathione: effect on plasma concentration